If you follow us on Twitter you may know that we presented our progress with OpenTrials at the Evidence Live conference in Oxford a few weeks ago. Amongst those attending were leaders across the world of Evidence Based Medicine, including researchers, doctors, and the pharmaceutical industry, so we were excited to participate!
It was great to speak to so many people who are interested in OpenTrials, both in terms of researchers who want to use the platform and those with a general enthusiasm for its impact on medicine.
Around 40 people attended our talk which explained why OpenTrials is an important infrastructure project for medicine, covered some of the technical aspects of the platform, details of what data we’ve imported so far, and lastly a quick demo.
If you’re feeling impatient, here are the slides from the talk, or scroll down for a summary.
Ben Goldacre and Vitor Baptista present OpenTrials at Evidence Live 2016 (photo by benmeg / CC BY)
What we’ve imported into the OpenTrials database so far
- ~22,000 research summaries from the Health Research Authority
- ~510,000 publications from PubMed (~24,000 linked with trials)
- Basic search (by keyword)
- Searching for trials with publications
- Uploading missing data/documents for a particular trial
- Showing trials with discrepancies (e.g. target sample size)
What we’re importing next
- Systematic Reviews from:
- Epistemonikos (26 sources)
- Clinical Study Report Synopses (e.g. YODA)
- Cochrane Schizophrenia data
- FDA Drug Approval Packages – OpenTrialsFDA won $80,000 to develop prototype to unlock ‘hidden’ data in non-searchable PDFs
Feedback and get involved
If you attended the talk and have any questions or feedback, please email us. And generally if you’re interested in contributing to OpenTrials, get in touch.
Want to get early access to the data and be a user tester? Sign up and we’ll be in touch soon.